Linear AD-sequence fragments enable nucleic acid loading into empty AAV particles without denaturation, preserving infectious activity and lowering cytotoxicity.
Recombinant plasmids boost miRNA production to degrade CXCR2 mRNA, helping restore immune homeostasis when CXCR2 is overexpressed.
Separate adenoviral vectors for AAV Rep and Cap raise rAAV yield while improving production stability and scale-up for clinical supply.
Recombinant plasmids boost miRNA against CXCR3 mRNA, lowering overexpression and helping restore immune homeostasis.
Recombinant plasmids boost miRNA production to degrade or inactivate CXCR2 mRNA, helping restore homeostatic balance in disease.